Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
fat emulsion therapy
fat overload syndrome
iatrogenic neurologic disorders
mental status, abnormal
seizure
seizure, focal
Showing articles 800 to 850 of 10746 << Previous Next >>

Cytotoxic Lesions of the Corpus Callosum Caused by Thermogenic Dietary Supplements
AJNR 40:1304-1308, Galnares-Olalde, J.A.,et al, 2019

Pes Cavus and Neuropathy
Neurol 93:e823-e826, Alderson,J.,& Ghosh,P.S., 2019

Changing Patterns of Carotid Endarterectomy Between 2011 and 2017 in England, A Population-Based Cohort Study
Stroke 50:2461-2468, , 2019

Declining Malformation Rates with Changed Antiepileptic Drug Prescribing, An Observational Study
Neurol 93:e831-e840, Tomson,T.,et al, 2019

Case 27-2019:A 16-Year-Old Girl with Head Trauma During a Sailboat Race
CPC,Concussion,Benign Paroxysmal Positional Vertigo, Case 27-2019, NEJM 381:863-871, Iaccarino,M.A.,et al, 2019

Spinal Cord Tumors
www.UptoDate.com, Feb, Welch, W.C.,et al, 2019

Acute Treatment of Migraine in Children and Adolescents
Neurol 93:487-499, Oskoui, M.,et al, 2019

Pharmacologic Treatment for Pediatric Migraine Prevention
Neurol 93:500-509, Oskoui, M.,et al, 2019

Dupuytren, Ledderhose, and Peyronie Diseases after Primidone Use for Essential Tremor
Neurologist 24:150-151, Felipe, L.,et al, 2019

Medical Use of Cannabis in 2019
JAMA 322:974-975, Hill, K.P., 2019

Neurolymphomatosis
Neurol 93:e1229-e1230, DeBoer, S.R.,et al, 2019

Fremanezumab versus Placebo for Migraine Prevention in Patients with Documented Failure to Up to Four Migraine Preventive Medication Classes (FOCUS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3� Trial
Lancet 394:1030-1040, Ferrari, M.D.,et al, 2019

Systemic Review of Malpractice Litigation in the Diagnosis and Treatment of Acute Stroke
Stroke 50:2858-2864, Haslett, J.J.,et al, 2019

Outcomes of Surgery for Brainstem Cavernous Malformations
Stroke 50:2964-2966, Kearns, K.N.,et al, 2019

Long-Term Safety and Efficacy of Eculizumab in Generalized Myasthenia Gravis
Muscle Nerve 60:14-24, Muppidi, S.,et al, 2019

Vaccine-Preventable Infections and Immunization in Multiple Sclerosis
Neurol 93:584-594, Farez, M.F.,et al, 2019

Ehlers-Danlos Syndromes
BMJ 366:I4966, Ghali, N.,et al, 2019

Stridor in Multiple System Atrophy
Neurol 93:630-639, Cortelli, P.,et al, 2019

An Intracerebral Hemorrhage Care Bundle is Associated with Lower Case Fatality
Ann Neurol 86:495-493, Parry-Jones, A.R.,et el, 2019

Neurosyphilis
NEJM 381:1358-1363, Ropper, A.H.,et al, 2019

Inebilizumab for the Treatment of Neuromyelitis Optica Spectrum Disorder (N-MOmentum): A Double-Blind, Randomised Placebo-Controlled Phase 2/3 Trial
Lancet 394:1352-1363,1304, Cree, B.A.C.,et al, 2019

Effects of Tranexamic Acid on Death, Disability, Vascular Occlusive Events and Other Morbidities in Patients with Acute Traumatic Brain Injury (CRASH-3): A Randomised, Placebo-Controlled Trial
Lancet 394:1713-1723,1687, The CRASH-3 trial collaborators, 2019

Clinical Effectiveness of Direct Oral Anticoagulations vs Warfarin in Older Patients with Atrial Fibrillation and Ischemic Stroke
JAMA Neurol 76:1192-1202, Xian, Y.,et al, 2019

Tics and Functional Tic-Like Movements
Neurol 93:750-758, Ganos, C.,et al, 2019

Diagnosis and Management of Dementia
JAMA 322:1589-1599, Arvanitakis, Z.,et al, 2019

Acute Vestibular Migraine Treatment with Noninvasive Vagus Nerve Stimulation
Neurol 93:e1715-e1719, Beh, S.C. & Friedman, D.I., 2019

Optic Nerve Enhancement and Restricted Diffusion in Postoperative Visual Loss
Neuro-Ophthalmol 43:337-339, Finelli, P.F., 2019

Intravenous Thrombolysis for Suspected Ischemic Stroke with Seizure at Onset
Ann Neurol 86:770-779, Polymeris, A.A.,et al, 2019

Sydenham Chorea
www.UptoDate.com, Oct, Gilbert, D.L., 2019

Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019

Automated CT Perfusion Imaging for Acute Ischemic Stroke
Neurol 93:888-898, Vagal, A.,et al, 2019

In-Hospital Outcomes of Transcarotid Artery Revascularization and Carotid Endarterectomy in the Society for Vascular Surgery Vascular Quality Initiative
J Vasc Surg DOI:10.1016/J.JVS.2018.11.029, Schermerhorn,M.L.,et al, 2019

Therapeutic-Induced Hypertension in Patients with Noncardioembolic Acute Stroke
Neurol 93:e1955-e1963, Bang,O.H.,et al, 2019


Neurol 93:975-977, Barghouthi, T.,et al, 2019

Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke
Stroke 50:e344-e418, Powers, W.J.,et al, 2019

Diagnosis and Treatment of Sciatica
BMJ 367:I6273, Jensen, R.K.,et al, 2019

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
NEJM 381:2103-2113,2171, Kapur, J.,et al, 2019

Muscular Dystrophies
Lancet 394:2025-2038, Mercuri, E.,et al, 2019

No-Cutoff Large Vessel Occlusion Stroke
Neurol 93;1014-1015, Atchaneeyasakul, K.,et al, 2019

Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019

Three-year Follow-up of Prospective Trial of Focused Ultrasound Thalamotomy for Essential Tremor
Neurol 93:e2284-e2293, Halpern, C.H.,et al, 2019

Automated ASPECTS in Acute Ischmeic Stroke: A Comparative Analysis with CT Perfusion
AJNR 40:2033-2038, Sundaram, V.K.,et al, 2019

Association of Transcarotid Artery Revascularization vs Transfemoral Carotid Artery Stenting with Stroke or Death Among Patients with Carotid Artery Stenosis
JAMA 322:2313-2322, Schermerhorn, M.L.,et al, 2019

Lyme Disease: What the Neuroradiologist Needs to Know
AJNR 40:1998-2000, Valand, H.A.,et al, 2019

GQ1b-Seronegative Miller Fisher Syndrome Associated with Pembrolizumab
J Neuro-Ophthal 39:394-396, Green, K.E.,et al, 2019

A 17-year-old Baseball Player with Right Hand Weakness
Neurol 92:e76-e80, Vachon, C. & Libdeh, A.A., 2019

Impact of Microbleeds on Outcome Following Recanalization in Patients with Acute Ischemic Stroke
Stroke 50:127-134, Choi, K.H.,et al, 2019

The Dangers of PRES
Neurol 92:e282-e285, Chaterine, C.,et al, 2019

Association of Initial Disease-Modifying Therapy with Later Conversion to Secondary Progressive Multiple Sclerosis
JAMA 32:175-187, Brown, J.W.L.,et al, 2019

Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients with Relapsing-Remitting Multiple Sclerosis
JAMA 32:165-174,153, Burt, R.K.,et al, 2019



Showing articles 800 to 850 of 10746 << Previous Next >>